Antitope to Present at "2^nd Annual Conference on Recombinant Antibodies" Melia Hotel, Berlin, Feb 27th 2008

Dr Matthew Baker, Chief Scientific Officer, will be presenting a paper entitled "Assessment of T-cell Epitopes as a Key Risk Factor in the Development of Anti-Therapeutic Immune Responses".